Innocent Mboudjeka

The Ability of an Oligomeric Human Immunodeficiency Virus Type 1 (HIV-1) Envelope Antigen To Elicit Neutralizing Antibodies against Primary HIV-1 Isolates Is Improved following Partial Deletion of the Second Hypervariable Region

Susan W. Barnett, Shan Lu, I Srivastava et al. · Journal of Virology · 2001 · 218 citations · Full text

Life Sciences, Immunology, Infectious Diseases +15

Human Immunodeficiency Virus Type 1 Intergroup (M/O) Recombination in Cameroon

Jun Takehisa, Léopold Zekeng, Eiji Ido et al. · Journal of Virology · 1999 · 130 citations · Full text

Life Sciences, Genetics, Microbiology +17

Polyvalent HIV-1 Env vaccine formulations delivered by the DNA priming plus protein boosting approach are effective in generating neutralizing antibodies against primary human immunodeficiency virus type 1 isolates from subtypes A, B, C, D and E

Shixia Wang, Ranajit Pal, John R. Mascola et al. · Virology · 2006 · 113 citations

Life Sciences, Immunology, Infectious Diseases +16

Various Types of HIV Mixed Infections in Cameroon

Jun Takehisa, Léopold Zekeng, Eiji Ido et al. · Virology · 1998 · 107 citations

Public Health, Infectious Diseases, Microbiology +14

Enhanced Immunogenicity of gp120 Protein When Combined with Recombinant DNA Priming To Generate Antibodies That Neutralize the JR-FL Primary Isolate of Human Immunodeficiency Virus Type 1

Shixia Wang, James Arthos, Donald Van Ryk et al. · Journal of Virology · 2005 · 101 citations

Life Sciences, Immunology, Infectious Diseases +17